Longeveron LGVN

€ 1.78 -0.53%

Quartalsbericht 2024-Q3
hinzugefügt 12.11.2024

Andere Aktien der Branche "Pharmaeinzelhändler"

Name	Preis	% 24h	Marktkapitalisierung	Börse	Land
Sorrento Therapeutics SRNE	$ 0.27	-29.58 %	$ 126 M	Nasdaq Global Select Market	USA
Corbus Pharmaceuticals Holdings CRBP	$ 10.41	-5.36 %	$ 43.9 M	Nasdaq Global Market	USA
Apellis Pharmaceuticals APLS	$ 28.64	3.21 %	$ 3.4 B	Nasdaq Global Select Market,SPB	USA
Axsome Therapeutics AXSM	$ 98.59	0.41 %	$ 4.48 B	Nasdaq Global Market,SPB	USA
ContraFect Corporation CFRX	$ 1.47	-5.16 %	$ 5.39 M	Nasdaq Capital Market	USA
Orchard Therapeutics plc ORTX	$ 4.93	1.02 %	$ 90.8 M	Nasdaq Global Select Market	Britain
Bristol-Myers Squibb Company BMY	$ 58.05	-0.31 %	$ 120 B	NYSE,SPB	USA
Black Diamond Therapeutics BDTX	$ 2.44	0.37 %	$ 107 M	Nasdaq Global Select Market,SPB	USA
Advaxis ADXS	$ 0.31	-9.65 %	$ 45.9 M	Nasdaq Capital Market	USA
Heat Biologics, Inc. HTBX	$ 3.93	-5.76 %	$ 99.8 M	Nasdaq Capital Market	USA
Bio-Path Holdings BPTH	$ 0.75	-6.01 %	$ 358 K	Nasdaq Capital Market	USA
La Jolla Pharmaceutical Company LJPC	$ 6.2	-	$ 154 M	Nasdaq Capital Market	USA
Zymeworks ZYME	$ 6.42	-	$ 404 M	NYSE	Canada
Checkmate Pharmaceuticals CMPI	$ 10.5	-	$ 231 M	Nasdaq Global Market	USA
Kadmon Holdings, Inc. KDMN	$ 9.5	-	$ 1.7 B	Nasdaq Global Select Market	USA
BioDelivery Sciences International BDSI	$ 2.58	-4.8 %	$ 255 M	Nasdaq Global Select Market	USA
Zosano Pharma Corporation ZSAN	$ 0.56	7.23 %	$ 2.72 M	Nasdaq Global Select Market	USA
Ayala Pharmaceuticals AYLA	$ 0.5	-	$ 7.46 M	Nasdaq Global Market	Israel
Coherus BioSciences CHRS	$ 1.11	0.92 %	$ 105 M	Nasdaq Global Market	USA
Acceleron Pharma Inc. XLRN	$ 179.68	-	$ 10.9 B	Nasdaq Global Market,SPB	USA